Small molecule-based Life-span extension therapy: Orphan nuclear receptor NUR77 incrases energy expenditure and extends life span by up regulating the expression of FGF21, 28/April/2015, 6.08 am

Small molecule-based Life-span extension therapy: Orphan nuclear receptor NUR77 incrases energy expenditure and extends life span by up regulating the expression of FGF21, 28/April/2015, 6.08 am

Small molecule-based Life-span extension therapy: Orphan nuclear receptor NUR77 incrases energy expenditure and extends life span by up regulating the expression of FGF21, 28/April/2015, 6.08 am 150 150 Dr Boomi's Genom-2-Discovery Center

Idea Proposed/Formulated byDr L Boominathan Ph.D.

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

CitationBoominathan, L., Small molecule-based Life-span extension therapy: Orphan nuclear receptor NUR77 incrases energy expenditure and  extends life span by up regulating the expression of  FGF21, 28/April/2015, 6.08 am, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Web: http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org

* Research cooperation

Significance: This study suggests, for the first time, that NUR77, by increasing the expression of its target gene,  it may increase the expression of metabolite hormone FGF21. Thereby, it may increase energy expenditure and extend the lifespan of an individual. Thus, pharmacological formulations encompassing NUR77 activators may be used to extend the life-span of an individual.

Undisclosed information: How NUR77 suppresses the expression of  FGF21.